1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, July 2017

Biotechnology Analysis & Statistics in the United States, July 2017

1-30 of about 1400 reports

Purchase Reports From Reputable Market Research Publishers

Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cell-based assays market projected to grow at a CAGR of 8.4% during the forecast period” The global cell-based assays market is expected to reach USD 19.92 billion by 2022, at a CAGR of 8.4% from ...

  • Industries : In Vitro Diagnostics, Medical Device
  • Countries : World, Asia, Europe, North America, United States

Radiotherapy Market by Type, Internal & Systemic, Product, Application, End User, and Region - Global Forecasts to 2022

  • $ 5650
  • Industry report
  • June 2017
  • by MarketsandMarkets

“Radiotherapy market projected to grow at a CAGR of 6.8%.” The global radiotherapy market is expected to reach USD 9.47 billion by 2022 from USD 6.81 billion in 2017, at a CAGR of 6.8%. The rapidly ...

  • Industries : Cancer, Pathology, Health Services
  • Countries : World, North America, United States, Europe

GMO Testing Market by Trait, Technology, Crop Tested, Processed Food Tested, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • June 2017
  • by MarketsandMarkets

“GMO testing market is projected to grow at a CAGR of 8.2%” The GMO testing market, estimated at USD 1.58 billion in 2017, is projected to grow at a CAGR of 8.2%, to reach USD 2.34 billion by 2022. ...

  • Industries : Food Policy, Food, Agricultural Products
  • Countries : World, North America, United States, Asia, Europe

NGS-based RNA-seq Market by Products & Services, Technology, Application, End User - Global Forecast to 2022

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

The global NGS-based RNA-seq market is projected to reach USD 2.65 billion by 2022 from USD 1.05 billion in 2017, at a CAGR of 20.2%. Factors such as the advantages of RNA-seq over microarray technology, ...

  • Industries : Genomics, Biotechnology
  • Countries : World, North America, United States

Protein Assays Market by Product, Type, Application, Technology, End User - Global Forecasts to 2022

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

The protein assays market is expected to reach USD 1.42 billion by 2017 and is projected to grow at a CAGR of 11.1% between 2017 and 2022, to reach USD 2.41 billion in 2022. Protein assays are used in ...

  • Countries : North America, World, United States

High-Resolution Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global high-resolution melting analysis market is expected to reach USD 302.1 million by 2021 from USD 259.4 million in 2016, at a CAGR of 3.1% during the forecast period of 2016 to 2021. On the basis ...

  • Industries : Genomics, Biotechnology
  • Countries : Europe, World, North America, United States, Asia

Global Stem Cells Industry

  • $ 4950
  • Industry report
  • May 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Stem Cell Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, ...

  • Industries : Biological Therapy
  • Countries : United States, World, Europe

Global Genetic Testing Industry

  • $ 4950
  • Industry report
  • May 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is further analyzed by the following Segments: Prenatal & Newborn Genetic Testing, Pharmacogenomic Testing, ...

  • Industries : Genomics
  • Countries : World, United States, Europe

Global Nanobots Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • April 2017
  • by Accuray Research LLP

The Global Nanobots Market is poised to grow at a CAGR of around xx% over the next decade to reach approximately $xx billion by 2025. This industry report analyzes the market estimates and forecasts of ...

  • Industries : Biotechnology
  • Countries : United States

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • June 2017
  • by GlobalData

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, “Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : United States

US Market Overview for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedView

  • $ 3995
  • Industry report
  • July 2017
  • by iData Research, Inc.

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - ...

  • Industries : Advanced Material, Biomaterial, Biomaterial
  • Countries : United States

Transplantation Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • July 2017
  • by GBI Research

Transplantation Drug Development Pipeline Review, 2017 Summary This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection ...

  • Industries : Healthcare, Blood Supply, Tissue Banking and Transplantation
  • Countries : United States

Skeletal Disease Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • July 2017
  • by GBI Research

Skeletal Disease Drug Development Pipeline Review, 2017 Summary This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • June 2017
  • by GlobalData

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026 Summary GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland (CGF, 2003). The ...

  • Industries : Health Services, Biopharmaceutical
  • Countries : Japan, United States

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017

  • $ 3995
  • Company report
  • May 2017
  • by GBI Research

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017 Summary This report provides an overview of the toxicology pipeline landscape. The report provides comprehensive ...

  • Industries : Therapy, Oncology, Pathology
  • Countries : United States

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2017 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) pipeline Target constitutes close to ...

  • Industries : Therapy
  • Countries : World, United States

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen ...

  • Industries : Pathology, Therapy, Cancer, Pharmaceutical, Biological Therapy
  • Countries : United States, World

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Pipeline Review, H2 2017 Summary Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States, World

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2017 Summary Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Interleukin-7 receptor is a protein found ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : World, United States, Europe, France

Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Landscape, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • July 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2017 Summary Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (?3) o ...

  • Industries : Pathology, Therapy, Healthcare, Health Services
  • Countries : United States

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2017 Summary According to the recently published report ’Granulocyte Macrophage ...

  • Industries : Therapy, Biological Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World

Cell Surface Marker Testing Market 2021: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • June 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, Italy, United Kingdom, Japan

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2017 Summary Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H1 2017 Summary Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Dystrophin (DMD) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Dystrophin (DMD) - Pipeline Review, H1 2017 Summary According to the recently published report 'Dystrophin (DMD) - Pipeline Review, H1 2017'; Dystrophin (DMD) pipeline Target constitutes close to 26 molecules. ...

  • Industries : Mental Health, Therapy, Pharmaceutical, Pathology
  • Countries : United States

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2017 Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a protein ...

  • Industries : Therapy
  • Countries : World, United States

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H1 2017 Summary Probable ATP ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, Europe, United States

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2017 Summary Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) pipeline Target constitutes close ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States

Interleukin 1 (IL1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Interleukin 1 (IL1) - Pipeline Review, H1 2017 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 28 molecules. Out of which approximately 27 molecules are developed by companies and remaining ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : World, United States, Europe

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.